ADC Therapeutics SA - Stock Price History | ADCT

Historical daily share price chart and data for ADC Therapeutics SA since 2021 adjusted for splits. The latest closing stock price for ADC Therapeutics SA as of September 27, 2021 is 29.69.
  • The all-time high ADC Therapeutics SA stock closing price was 51.05 on July 02, 2020.
  • The ADC Therapeutics SA 52-week high stock price is 38.34, which is 29.1% above the current share price.
  • The ADC Therapeutics SA 52-week low stock price is 20.01, which is 32.6% below the current share price.
  • The average ADC Therapeutics SA stock price for the last 52 weeks is 27.67.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
ADC Therapeutics SA Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 38.0118 29.6500 51.0500 25.2600 32.0100 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.949B $0.002B
ADC Therapeutics SA is a late clinical-stage oncology-focused biotechnology company. It engages in development and commercialization of antibody drug conjugates for patients suffering from hematological malignancies and solid tumors. ADC Therapeutics SA is based in LAUSANNE, Switzerland.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $133.838B 8.91
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.341B 20.90
Biohaven Pharmaceutical Holding (BHVN) United States $8.723B 0.00
Emergent Biosolutions (EBS) United States $2.813B 6.79
Arcus Biosciences (RCUS) United States $2.568B 0.00
Myovant Sciences (MYOV) United Kingdom $2.170B 0.00
Zymeworks (ZYME) Canada $1.323B 0.00
Ambrx Biopharma (AMAM) United States $0.509B 0.00
SQZ Biotechnologies (SQZ) United States $0.428B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29